{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:04:55Z","timestamp":1789535095397,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the associations of obesity\u2013metabolic phenotypes with coronary artery disease (CAD) prevalence and to evaluate the interaction between obesity and metabolic unhealthiness and the potential mediating role of high-sensitivity C-reactive protein (hsCRP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 860 participants were classified as metabolically healthy non-obese (MHNO), metabolically healthy obesity (MHO), metabolically unhealthy non-obese (MUNO), or metabolically unhealthy obesity (MUO). Associations with CAD prevalence were estimated using modified Poisson regression with robust variance. Interactions between obesity and metabolic unhealthiness were assessed on multiplicative and additive scales. Subgroup and sensitivity analyses were performed, followed by an exploratory mediation analysis of hsCRP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 860 participants, 563 (65.5%) had CAD. After adjustment for age, sex, current smoking, alcohol use, family history of CAD, lipoprotein(a) [Lp(a)], low-density lipoprotein cholesterol (LDL-C), and estimated glomerular filtration rate (eGFR), the prevalence ratios for CAD were 1.51 [95% confidence interval (CI), 1.26\u20131.81] for MHO, 1.73 (95% CI, 1.48\u20132.02) for MUNO, and 1.79 (95% CI, 1.53\u20132.10) for MUO compared with MHNO (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Negative interactions between obesity and metabolic unhealthiness were observed on both the multiplicative scale (interaction ratio, 0.69; 95% CI, 0.56\u20130.84) and the additive scale [relative excess due to interaction (RERI), \u22120.44; 95% CI, \u22120.79 to \u22120.13]. Results were consistent across sensitivity analyses. Exploratory mediation analysis showed average indirect effects through hsCRP of 1.94, 5.93, and 8.20 percentage points for MHO, MUNO, and MUO, respectively, corresponding to proportions mediated of 9.4%, 19.6%, and 23.6%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MHO, MUNO, and MUO were all associated with higher CAD prevalence, with stronger associations observed for metabolically unhealthy phenotypes. Obesity and metabolic unhealthiness showed a negative interaction. Exploratory findings indicated an hsCRP-related indirect association, but causal mediation cannot be inferred from this cross-sectional study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1961932","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:34:57Z","timestamp":1789533297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of obesity\u2013metabolic phenotypes with coronary artery disease prevalence: interaction and exploratory mediation analyses of high-sensitivity C-reactive protein"],"prefix":"10.3389","volume":"13","author":[{"given":"Chunjing","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Cangzhou People's Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cangzhou People's Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"bnaa004","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically healthy obesity","volume":"41","author":"Bl\u00fcher","year":"2020","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41366-026-02056-9","article-title":"Metabolically healthy obesity is independently associated with 20-year incidence of cardiovascular disease: findings from the ATTICA cohort study (2002\u20132022)","volume":"50","author":"Filippatos","year":"2026","journal-title":"Int J Obes (Lond)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/dom.16040","article-title":"The impact of metabolic heterogeneity of obesity and transitions on cardiovascular disease incidence in Chinese middle-aged and elderly population: a nationwide prospective cohort study","volume":"27","author":"He","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12872-026-05849-y","article-title":"Associations between metabolic obesity phenotypes and incident cardiovascular disease in middle-aged and elderly Chinese individuals","volume":"26","author":"Wang","year":"2026","journal-title":"BMC Cardiovasc Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2337\/dc20-1760","article-title":"Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain","volume":"44","author":"Kammerlander","year":"2021","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.numecd.2018.11.002","article-title":"Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: results from the heinz nixdorf recall cohort study","volume":"29","author":"Kowall","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/diagnostics14131314","article-title":"Risk of cardiovascular events in metabolically healthy overweight or obese adults: role of LDL-cholesterol in the stratification of risk","volume":"14","author":"Palatini","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"00445","DOI":"10.1016\/j.jacl.2026.07.015","article-title":"Apolipoprotein B-low-density lipoprotein cholesterol discordance refines cardiovascular risk stratification across metabolic phenotypes","author":"Kim","year":"2026","journal-title":"J Clin Lipidol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.numecd.2023.09.002","article-title":"Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: a systematic review and meta-analysis","volume":"34","author":"Su","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11540","DOI":"10.3390\/ijms252111540","article-title":"Systemic inflammation across metabolic obesity phenotypes: a cross-sectional study of Korean adults using high-sensitivity C-reactive protein as a biomarker","volume":"25","author":"Baek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1038\/s41598-024-57751-2","article-title":"Cardiometabolic profiles and proteomics associated with obesity phenotypes in a longitudinal cohort of young adults","volume":"14","author":"Liao","year":"2024","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1759522","DOI":"10.3389\/fcvm.2026.1759522","article-title":"Metabolic syndrome and high-sensitivity C-reactive protein co-modify the risk of coronary artery calcification","volume":"13","author":"Chen","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","article-title":"Inflammation and cardiovascular disease: 2025 ACC scientific statement: a report of the American College of Cardiology","volume":"87","author":"Mensah","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1111\/dom.14492","article-title":"Metabolically healthy obesity and cardiovascular events: a nationwide cohort study","volume":"23","author":"Fauchier","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.numecd.2024.04.001","article-title":"Association between metabolic phenotypes of overweight\/obesity and cardiovascular diseases in postmenopausal women","volume":"34","author":"Deng","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e028502","DOI":"10.1161\/JAHA.122.028502","article-title":"Sex-specific impact of body weight on atherosclerotic cardiovascular disease incidence in individuals with and without ideal cardiovascular health","volume":"12","author":"Paulin","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2023.01.024","article-title":"Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: results from SCAPIS","volume":"373","author":"Bergstr\u00f6m","year":"2023","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e218505","DOI":"10.1001\/jamanetworkopen.2021.8505","article-title":"An empirically derived definition of metabolically healthy obesity based on risk of cardiovascular and total mortality","volume":"4","author":"Zembic","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/met.2009.0059","article-title":"Metabolic syndrome and angiographic coronary artery disease prevalence in association with the framingham risk score","volume":"8","author":"Konstantinou","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e12523","DOI":"10.1111\/cob.12523","article-title":"Cardiometabolic risk factors in adults with normal weight obesity: a systematic review and meta-analysis","volume":"12","author":"Rakhmat","year":"2022","journal-title":"Clin Obes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e72028","DOI":"10.1002\/hsr2.72028","article-title":"Abdominal obesity phenotypes and incidence of type 2 DM, cardiovascular outcomes and all-cause mortality: a systematic review and meta-analysis","volume":"9","author":"Doustmohamadian","year":"2026","journal-title":"Health Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12872-026-05928-0","article-title":"Dynamic associations of BMI-metabolic phenotype transitions with incident cardiovascular disease in middle-aged and elderly adults: a longitudinal cohort study","volume":"26","author":"Zhao","year":"2026","journal-title":"BMC Cardiovasc Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/metabo16070510","article-title":"Longitudinal transitions of metabolic-obesity phenotypes and subsequent cardiovascular disease risk: a prospective analysis of the CHARLS cohort","volume":"16","author":"Yan","year":"2026","journal-title":"Metabolites"},{"key":"B25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13679-023-00494-4","article-title":"Metabolically healthy obesity: are interventions useful?","volume":"12","author":"Mathis","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s11886-024-02127-1","article-title":"Impact of visceral and hepatic fat on cardiometabolic health","volume":"26","author":"Khawaja","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.numecd.2023.12.024","article-title":"Visceral adiposity associated with incidence and development trajectory of cardiometabolic diseases: a prospective cohort study","volume":"34","author":"He","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/j.jacl.2024.04.001","article-title":"Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity medicine association and the national lipid association 2024","volume":"18","author":"Bays","year":"2024","journal-title":"J Clin Lipidol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrendo.2014.185","article-title":"Biology of upper-body and lower-body adipose tissue\u2013link to whole-body phenotypes","volume":"11","author":"Karpe","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e51698","DOI":"10.7759\/cureus.51698","article-title":"The influence of anthropometrics on cardiac mechanics in healthy women with opposite obesity phenotypes (android vs gynoid)","volume":"16","author":"Sonaglioni","year":"2024","journal-title":"Cureus"},{"key":"B31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7570\/jomes24013","article-title":"Understanding adipose tissue dysfunction","volume":"33","author":"Bl\u00fcher","year":"2024","journal-title":"J Obes Metab Syndr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1153915","DOI":"10.3389\/fimmu.2023.1153915","article-title":"Adipose tissue macrophages as potential targets for obesity and metabolic diseases","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","article-title":"Inflammation and resolution in obesity","volume":"21","author":"Sot\u00e1k","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"21761","DOI":"10.1038\/s41598-023-48602-7","article-title":"Inflammatory burden, lifestyle and atherosclerotic cardiovascular disease: insights from a population based cohort study","volume":"13","author":"Bay","year":"2023","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/eurjpc\/zwad197","article-title":"Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: atherosclerosis risk in communities study","volume":"30","author":"Jia","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9129","DOI":"10.3390\/ijms24119129","article-title":"C-reactive protein levels and risk of cardiovascular diseases: a two-sample bidirectional Mendelian randomization study","volume":"24","author":"Kuppa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"8584","DOI":"10.1038\/s41598-026-39691-1","article-title":"Residual inflammatory risk and clinical outcomes after contemporary percutaneous coronary intervention: a systematic review and meta-analysis","volume":"16","author":"Romeo","year":"2026","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"104566","DOI":"10.1016\/j.numecd.2026.104566","article-title":"The joint effect of cardiometabolic index and high-sensitivity C-reactive protein on incident cardiovascular disease: a prospective cohort study","volume":"36","author":"Zhou","year":"2026","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-026-02227-8","article-title":"Relationship between hs-CRP-triglyceride glucose index and coronary plaque morphology: insights from optical coherence tomography","author":"Yao","year":"2026","journal-title":"Diabetol Metab Syndr"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1961932\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:35:07Z","timestamp":1789533307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1961932\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":42,"alternative-id":["10.3389\/fcvm.2026.1961932"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1961932","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1961932"}}